| Scott Ryan Lundberg, MD | |
|
14445 Olive View Drive, Room 2b182 Medicine, Sylmar, CA 91342 | |
| (818) 364-3205 | |
| (818) 364-3044 |
| Full Name | Scott Ryan Lundberg |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 14445 Olive View Drive, Sylmar, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770518789 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A73074 (California) | Primary |
| 207R00000X | Internal Medicine | A73074 (California) | Primary |
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.
Simple yet structured exercise can significantly improve kidney disease patients' quality of life as well as decrease their pain, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
InSysBio continues to investigate the mechanisms underlying Alzheimer's disease using the quantitative systems pharmacology modeling approach. The part of QSP model describing tau protein was published in the PLOS ONE journal. This is one of more than dozen InSysBio publications in AD area during last seven years.
A team of researchers at the Worcester Polytechnic Institute (WPI) Life Sciences and Bioengineering Center at Gateway Park has developed a new model system to study fungal infections. The system can be a powerful tool for screening potential drug targets for conditions like thrush, athlete's foot and vaginal yeast infections, which affect millions of people each year but are difficult to treat with existing medications. Using the new model, the researchers also identified a gene that may be a promising target for a new anti-fungal drug.
In its continued health care fraud crackdown, the Obama administration announced Wednesday that charges were filed against 91 people in eight cities. These people are accused of bilking Medicare out of an estimated $300 million.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Ryan Lundberg, MD 14445 Olive View Drive, Room 2b182 Medicine, Sylmar, CA 91342 Ph: (818) 364-3205 | Scott Ryan Lundberg, MD 14445 Olive View Drive, Room 2b182 Medicine, Sylmar, CA 91342 Ph: (818) 364-3205 |
News Archive
Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.
Simple yet structured exercise can significantly improve kidney disease patients' quality of life as well as decrease their pain, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
InSysBio continues to investigate the mechanisms underlying Alzheimer's disease using the quantitative systems pharmacology modeling approach. The part of QSP model describing tau protein was published in the PLOS ONE journal. This is one of more than dozen InSysBio publications in AD area during last seven years.
A team of researchers at the Worcester Polytechnic Institute (WPI) Life Sciences and Bioengineering Center at Gateway Park has developed a new model system to study fungal infections. The system can be a powerful tool for screening potential drug targets for conditions like thrush, athlete's foot and vaginal yeast infections, which affect millions of people each year but are difficult to treat with existing medications. Using the new model, the researchers also identified a gene that may be a promising target for a new anti-fungal drug.
In its continued health care fraud crackdown, the Obama administration announced Wednesday that charges were filed against 91 people in eight cities. These people are accused of bilking Medicare out of an estimated $300 million.
› Verified 3 days ago
Dr. Reebu Kohli, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14445 Olive View Drive, Sylmar, CA 91342 Phone: 818-364-3205 | |
Dr. Arthur Jeng, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 14445 Olive View Dr, 2b182, Sylmar, CA 91342 Phone: 818-364-3205 Fax: 818-364-4573 | |
Dr. Christopher Lee Metchnikoff, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 14445 Olive View Dr # 2b-182, Sylmar, CA 91342 Phone: 747-210-3205 Fax: 747-210-4573 | |
Annie Chen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 14445 Olive View Dr, Sylmar, CA 91342 Phone: 747-210-3205 | |
Dr. John Cho, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14445 Olive View Drive, North Annex, Sylmar, CA 91342 Phone: 818-364-3632 | |
Caitlin G Reed, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 14445 Olive View Dr, Olive View-ucla Med Ctr, Dept Of Med, 2b-182, Sylmar, CA 91342 Phone: 818-364-3205 | |
Robert Nathan Titcher, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 14124 Foothill Blvd, Suite 100, Sylmar, CA 91342 Phone: 818-367-1012 Fax: 818-367-7570 |